Systematic review with meta‐analysis: associations between coeliac disease and type 1 diabetes

@article{Elfstrm2014SystematicRW,
  title={Systematic review with meta‐analysis: associations between coeliac disease and type 1 diabetes},
  author={Peter Elfstr{\"o}m and Johan Sundstr{\"o}m and J F Ludvigsson},
  journal={Alimentary Pharmacology \& Therapeutics},
  year={2014},
  volume={40}
}
In the past decade, a number of population‐based studies have examined the prevalence of coeliac disease in individuals with type 1 diabetes but prevalences have differed considerably. 

Frequency of auto‐antibodies of type 1 diabetes in adult patients with celiac disease

TLDR
It is shown that CD is associated with a high frequency of auto-antibodies of T1D in adult patients with active CD, and Screening for T2D in this population, at risk for other autoimmune diseases, may be useful.

Prevalence of celiac disease in a large cohort of young patients with type 1 diabetes

TLDR
The aim was to determine the prevalence of immunoglobulin‐A anti‐tissue transglutaminase antibodies (IgA‐tTG) and CD in a large cohort of young T1DM patients.

Use of olmesartan and enteropathy outcomes: a multi‐database study

Multiple case reports suggest that olmesartan may be linked to sprue‐like enteropathy; however, few epidemiological studies have examined this association and results have been mixed.

Diabetes: Microvascular complications in T1DM and coeliac disease

TLDR
Coeliac disease has been identified as a risk factor for retinopathy and nephropathy in patients who also have T1DM.

Current evidence on whether perinatal risk factors influence coeliac disease is circumstantial

TLDR
This review discusses the growing body of literature on coeliac disease and perinatal risk factors and highlights the need to understand more fully the role of the perinnatal environment in coelacio disease.

Celiac disease and Infections

TLDR
A small number of patients with a history of celiac disease and/or high-risk of gluten-related illnesses are diagnosed with atypical central giant cell granuloma, which is a leading cause of death in people with Celiac disease.

Screening for coeliac disease in adult patients with type 1 diabetes mellitus: myths, facts and controversy

TLDR
Based on the current evidence of effects of CD on bone mineral density, diabetic complications, quality of life, morbidity and mortality in patients with T1DM, periodic screening for CD in adult T1dm patients is advised to prevent delay in CD diagnosis and subsequent CD and/or T1 DM related complications.

Prevalence of celiac disease in Iranian patients with type 1 diabetes: A systematic review and meta-analysis

TLDR
The prevalence of celiac disease among Iranian patients with type 1 diabetes mellitus was estimated to be 5%, and meta-regression analysis showed that, with increasing sample size, the prevalence of CD was significantly reduced.

Relation between Anti-Transglutaminase IgA e Anti-Thyroperoxidase in a Pediatric Patient Cohort

TLDR
This poster focuses on the parts of the immune system that are involved in inflammation and atrophy and the role these factors play in the development of Celiac Disease.

Increased Incidence of Thyroid Disease in Patients with Celiac Disease: A Systematic Review and Meta-Analysis

TLDR
The hypothesis that the prevalence of thyroid disease in patients with CD is increased compared with that in controls, which suggests that CD patients should be screened for thyroid disease is supported, and the effect of gluten-free treatment on thyroid disease needs further investigation.
...

References

SHOWING 1-10 OF 78 REFERENCES

Increasing prevalence of coeliac disease over time

Background  The number of coeliac disease diagnoses has increased in the recent past and according to screening studies, the total prevalence of the disorder is around 1%.

Increasing prevalence of coeliac disease in Denmark: a linkage study combining national registries

Aim:  To determine the prevalence and incidence of diagnosed coeliac disease (CD) in Danish children and adolescents and to describe trends over time.

Coeliac disease in Type 1 diabetes from 1990 to 2009: higher incidence in young children after longer diabetes duration

Diabet. Med. 29, e286‐e289 (2012)

Prospective screening for biopsy proven coeliac disease, autoimmunity and malabsorption markers in Belgian subjects with Type 1 diabetes

Aims  To determine prospectively the prevalence of biopsy proven coeliac disease (CD) in an adult Type 1 diabetic population from Belgium with regards to associated auto‐immunity and malabsorption.

Annual screening detects celiac disease in children with type 1 diabetes

Objective:  To investigate the prevalence of celiac disease (CD) in a cohort of type 1 diabetes mellitus (T1DM) children and adolescents at the time of clinical diagnosis and to evaluate the

Celiac disease prevalence in children and adolescents with type 1 diabetes from Serbia

TLDR
The aim of the present study was to determine CD prevalence and its clinical manifestations in patients with T1DM.

Prevalence and clinical profile of celiac disease in type 1 diabetes mellitus in north India

TLDR
The aim was to study the prevalence and clinical profile of celiac disease in patients with type 1 diabetes mellitus in a tertiary care referral centre in north India.

Systematic review: worldwide variation in the frequency of coeliac disease and changes over time

Coeliac disease (CD), originally thought to be largely confined to Northern Europe and Australasia and uncommon in North America and the Middle East, is now recognised to be equally common in all

An update in the diagnosis of coeliac disease

Walker M M & Murray J A
(2011) Histopathology59, 166–179

Serological testing for coeliac disease in Type 1 diabetes mellitus: is immunoglobulin A level measurement necessary?

TLDR
This study evaluates the prevalence of IgA deficiency in individuals with Type 1 diabetes, compared with patients with coeliac disease and control subjects, and evaluates whether routine IgA measurement is justifiable when case finding for coleiac disease in patients with Type 2 diabetes.
...